Background: Essential oils (EOs) are a mixture of volatile compounds of plant origin, which possess substantial biological activities such as antioxidant, antimicrobial, and antifungal activity. Objective: This study aimed to determine the chemical composition, antioxidant, and antibacterial activity of essential oil isolated from Cymbopogon winterianus Jowitt. Methods:: The hydro-distillation method was used for the isolation of essential oil. The chemical composition of the isolated essential oil was analyzed using the gas chromatography/mass spectrometry (GC-MS) technique. Antioxidant activity was determined using a 2,2-diphenyl-1- picrylhydrazyl (DPPH) free radical scavenging assay, and the IC50 value was calculated. The welldiffusion method was applied for the antibacterial activity, and the zone of inhibition (ZOI) was measured. Results: The essential oil from Cymbopogon winterianus Jowitt was isolated with a 0.5% yield. Gas Chromatography-Mass Spectrometry(GC-MS) analysis reported 19 different compounds, out of which, Geraniol (28.87%), Citronellal (11.85%), Citronellol (10.88%), Geranial (9.19%), trans- Geranyl acetate (9.11%), and Neral (8.02%) were found to be the major constituents. The essential oil was a promising antioxidant with an IC50 value of 0.458±0.39μg/mL compared to the standard Quercetin of 1.187±0.22μg/mL. In addition, the isolated essential oil revealed antibacterial activity against Staphylococcus aureus (ZOI=13.2mm), Bacillus subtilis (ZOI=9.9mm), and Enterococcus faecalis (ZOI=8.4mm). Conclusions: The essential oil isolated from Cymbopogon winterianus Jowitt exhibits antioxidant and antibacterial activity, implying that it could find use in modern medicine.
Background: Diabetes has become a considerably more frequent condition and has increased alarmingly in recent years, possibly due to the adoption of modern lifestyle and food habits. The two prominent features of diabetes mellitus are high blood glucose and insulin deficiency, leading to severe consequences. Developing next-generation anti-diabetic medicines with fewer side effects has been a major focus in this situation.Objective: This research aimed to investigate the total phenolic and flavonoid content, antioxidant, antibacterial, α-amylase, and α-glucosidase inhibition activity, as well as in silico analysis of Mimosa pudica L.Methods: The inhibitory activity against α-amylase and α-glucosidase was performed using CNPG3 and PNPG, respectively. Antioxidant activity was estimated using DPPH free radical scavenging assay. The well diffusion method was used for the antibacterial. Using folin- ciocalteu’s reagent, the total phenolic content was determined. The total flavonoid content was determined using the aluminium trichloride method. In addition, molecular docking was performed using autodock vina.Results: Inhibition of α-glucosidase (IC50 = 1.059±0.14μg/mL) was found to be more significant than α-amylase (IC50 = 164.9±0.95μg/mL). The plant was also found to have antioxidant activity (IC50 = 8.207 ±0.23μg/mL), as well as antibacterial activity against Staphylococcus aureus (ZOI = 13mm) and Bacillus subtilis (ZOI = 10mm). Similarly, the total phenolic and flavonoid content was found to be 177.93±1.8 mg GAE/g, and 19.747±6.11 mg QE/g, respectively. In addition, compounds (stigmasterol, quercetin, and avicularin) isolated from M. pudica showed perfect binding to the enzyme’s active site.Conclusion: Mimosa pudica of Nepalese origin possess potent inhibition against digestive enzymes. Therefore, M. pudica can be used as an alternative therapeutic source to combat the global threat of diabetes.
Background: Diabetes mellitus is a metabolic disorder that has become a major health issue in the modern era due to long-term health consequences. α-amylase and α-glucosidase are the key enzymes involved in the digestion of starchy foods, and the inhibition of these enzymes is regarded as a postprandial hyperglycemia control strategy. Objective: The primary goal of this work is to examine the antioxidant activity as well as α- glucosidase inhibitory activity of Polygonatum verticillatum rhizomes via in vitro test. Methods: The in vitro α-glucosidase inhibition activity was performed using p-nitrophenyl-α- Dglucopyranoside (PNPG) substrate. 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging assay was performed to estimate the antioxidant activity. Results: The in vitro α-glucosidase inhibitory activity of Polygonatum verticillatum was investigated for the very first time. Of the three fractions and a crude extract, the ethyl acetate (EA) fraction disclosed potent inhibition activity against α-glucosidase enzyme with an IC50 value of 22.3 ± 0.1 μg/mL. Likewise, the IC50 values for dichloromethane (DCM) fraction and the crude extract against α- glucosidase were reported at 34 ± 0.1 μg/mL and 402.2 ± 0.2 μg/mL, respectively. Similarly, the EA fraction, crude extract, and DCM fraction disclosed promising antioxidant activity with IC50 = 55 ± 0.3 μg/mL, 171.5 ± 0.6 μg/mL, and 164.1 ± 3.4 μg/mL, respectively. Conclusion: These findings concluded that among the crude extract and fractions of Polygonatum verticillatum of Nepalese origin, the EA fraction constituted a potent α-glucosidase inhibiting and antioxidant agent. Further research is required to expose the inhibiting compounds.